FDA & EMA inspected

17 Oct 2019

CBL, the “Peptide Innovators” was recently inspected both by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Approvals were received from both agencies for the API manufacturing of octreotide.

This drug is used in the treatment of various cancers.

FDA & EMA inspected

Companies mentioned

Related categories